Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Medicine (London, England)|March 12, 2013
To what extent is NICE guidance on the management of rheumatoid arthritis in adults being implemented in clinical practice? A regional surveyNicola Tugnet, Fiona Pearce, Sofia Tosounidou, et al.
Clinical Rheumatology|April 13, 2011
Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamideAbhishek Abhishek, Ramin Yazdani, Fiona Pearce, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 17, 2021
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in SingaporeLi-Jen Cheng, Lydia Loke, Elaine Hsuen Lim, et al.
Journal of Medical Economics|April 18, 2020
Cost-effectiveness of sequential urate lowering therapies for the management of gout in SingaporeSil-Ling Pruis, Yunjoo Karris Jeon, Fiona Pearce, et al.
International Journal of Technology Assessment in Health Care|March 12, 2019
Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in SingaporeSil-Ling Pruis, Mohamed Ismail Abdul Aziz, Fiona Pearce, et al.
Rheumatology (Oxford, England)|December 3, 2020
Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemicEmily Peach, Megan Rutter, Peter Lanyon, et al.
Rheumatology (Oxford, England)|April 13, 2022
COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritisRené Cordtz, Salome Kristensen, Rasmus Westermann, et al.
International Journal of Technology Assessment in Health Care|July 29, 2025
Plain language summaries supporting patient involvement: lessons and guidance from HTAi Patient and Citizen Involvement Interest Group (PCIG)Martin Andrew Coombes, Kate Morgan, Jose Diaz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 15, 2020
Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in SingaporeLing Eng Tan, Wan Hui Gloria Tan, Mohamed Ismail Abdul Aziz, et al.
Pageof 4